CGA
CELG

Crescent Grove Advisors’s Celgene Corp CELG Stock Holding History

Crescent Grove Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,500
Closed -$313K – 170
2018
Q3 		$313K Hold
3,500
– – 0.07% 103
2018
Q2 		$278K Hold
3,500
– – 0.07% 111
2018
Q1 		$312K Buy
3,500
+300
+9% +$28.8K 0.08% 102
2017
Q4 		$334K Buy
+3,200
New +$361K 0.08% 93
2017
Q3 		– Sell
-2,200
Closed -$286K – 153
2017
Q2 		$286K Buy
+2,200
New +$270K 0.08% 103

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Crescent Grove Advisors's CELG Position: Q4 2018 in Review

Crescent Grove Advisors sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 3,500 shares — an estimated $313K sold.

Crescent Grove Advisors first reported a position in CELG in Q2 2017 and held it in 5 quarters. The position peaked at $334K in Q4 2017. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Crescent Grove Advisors reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • Crescent Grove Advisors sold 3,500 Celgene Corp shares in Q4 2018, an estimated $313K.
  • Crescent Grove Advisors first reported a position in Celgene Corp in Q2 2017 and held it in 5 quarters.
  • Crescent Grove Advisors's Celgene Corp position peaked at $334K in Q4 2017.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Crescent Grove Advisors's 13F filing for Q4 2018, filed 29 Jan 2019.